Previous Article | Next Article 
Infection and Immunity, May 1999, p. 2585-2589, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Interleukin-18 (IL-18) in Mycobacterial
Infection in IL-18-Gene-Disrupted Mice
Isamu
Sugawara,1,*
Hiroyuki
Yamada,1
Hirotaka
Kaneko,1
Satoru
Mizuno,1
Kiyoshi
Takeda,2 and
Shizuo
Akira2
Department of Molecular Pathology, The
Research Institute of Tuberculosis, Japan Anti-Tuberculosis
Association, Kiyose, Tokyo 204-0022,1 and
Department of Biochemistry, Hyogo College of Medicine,
Nishinomiya, Hyogo 663,2 Japan
Received 23 December 1998/Returned for modification 19 January
1999/Accepted 1 March 1999
 |
ABSTRACT |
Immunity to mycobacterial infection is closely linked to the
emergence of T cells that secrete cytokines, gamma interferon (IFN-
), interleukin-12 (IL-12), and tumor necrosis factor alpha (TNF-
), resulting in macrophage activation and recruitment
of circulating monocytes to initiate chronic granuloma formation. The cytokine that mediates macrophage activation is IFN-
,
and, like IL-12, IL-18 was shown to activate Th1 cells and induce
IFN-
production by these cells. In order to investigate the role of IL-18 in mycobacterial infection, IL-18-deficient mice were
infected with Mycobacterium tuberculosis and
Mycobacterium bovis BCG Pasteur, and their capacities to
control bacterial growth, granuloma formation, cytokine secretion, and
NO production were examined. These mice developed marked granulomatous,
but not necrotic, lesions in their lungs and spleens. Compared with the
levels in wild-type mice, the splenic IFN-
levels were low but the
IL-12 levels were normal in IL-18-deficient mice. The reduced IFN-
production was not secondary to reduced induction of IL-12
production. The levels of NO production by peritoneal macrophages of
IL-18-deficient and wild-type mice did not differ significantly.
Granulomatous lesion development by IL-18-deficient mice was inhibited
significantly by treatment with exogenous recombinant IL-18. Therefore,
IL-18 is important for the generation of protective immunity to
mycobacteria, and its main function is the induction of IFN-
expression.
 |
INTRODUCTION |
Gamma interferon (IFN-
) is
a cytokine secreted by activated T cells and natural killer (NK) cells.
It exerts various immunomodulatory effects on several types of cells
(25) and is one of the major cytokines responsible for
activating macrophages, which mediate nonspecific, cell-mediated,
host defenses (12, 20). IFN-
has been shown to be
an important mediator of macrophage activation involved in
controlling a number of intracellular pathogens, including Mycobacterium tuberculosis, Leishmania major,
Leishmania donovani, and Listeria monocytogenes
(2, 10, 14, 18). This protective immunity is closely
associated with emergence kinetics and loss of CD4 T cells that secrete
large amounts of IFN-
(17). IFN-
has been shown to
play a critical role in protective immunity, as demonstrated by the
severe disseminated form of tuberculosis observed in
IFN-
-gene-disrupted mice (4, 6). Recently, we also
developed IFN-
-gene-deficient mice (21, 22) and
demonstrated that endogenous IFN-
plays critical roles in
macrophage fusion, cell recruitment, and granuloma assembly
(21).
Interleukin-18 (IL-18) is a cytokine that has been identified in the
livers of mice treated with Propionibacterium acnes and lipopolysaccharide (15). This cytokine was originally
identified as an IFN-
-inducing factor, which induces IFN-
production by splenocytes, hepatic lymphocytes, and type 1 T helper
(Th1) cell clones (11, 13, 16). IL-18 appears to have
biological functions similar to those of IL-12, which is known to
possess immunoregulatory activities. However, IL-18 was
reported to be strikingly similar to the IL-1 family of cytokines
(1) and showed no similarity to IL-12 (24).
In order to determine the in vivo functions of IL-18 in
mycobacterial infection, we generated IL-18-deficient mice by gene targeting (23). We used these knockout (KO) mice as a model of systemic infection and showed that IL-18 is important for the development of protective immunity, although these mice infected with
M. tuberculosis did not develop the acute disseminated form of infection.
 |
MATERIALS AND METHODS |
Mice.
We disrupted the IL-18 gene by homologous
recombination in E14.1 embryonic stem cells, and a targeting vector was
constructed to replace a 3.0-kb fragment of genomic DNA containing
exons 3, 4, and 5 of the IL-18 gene with the neomycin resistance gene
(23). Heterozygous mice were crossed to produce mice
homozygous for the IL-18 gene mutation. IL-18-deficient C57BL/6 mice
were born at the expected Mendelian ratios and were phenotypically
normal and fertile. Their serum IL-18 concentrations, assessed by
enzyme-linked immunosorbent assay (ELISA), were below the detectable
level (the serum IL-18 concentration in normal C57BL/6 mice was
1,000 ± 20 pg/ml), indicating that the IL-18 gene mutation led to
a lack of IL-18 production.
Experimental infections.
The virulent Kurono strain (ATCC
358121) and the avirulent strain Mycobacterium bovis BCG
Pasteur (ATCC 27289) of M. tuberculosis were grown in
Middlebrook 7H9 medium (Difco) to the mid-log phase (21).
The cultured strains were filtered with a 4-µm-pore-size membrane
filter (Millipore) before use so that they were dispersed evenly.
IL-18-deficient and wild-type (WT) mice (10 mice/group) were infected
intravenously (i.v.) via a lateral tail vein with an inoculum of
106 to 107 CFU of Kurono or BCG Pasteur strain
suspended in 100 µl of phosphate-buffered saline (PBS). Mice were
infected by an airborne route by placing them in the exposure chamber
of an airborne infection apparatus (model 099CA4212; Glas-Col, Inc.,
Terre Haute, Ind.). The nebulizer compartment was filled with 5 ml of a
suspension of 105 to 106 CFU of Kurono or BCG
Pasteur strain at a concentration calculated to provide an uptake of
ca. 200 to 500 viable bacilli by the lungs just after inhalation
exposure during exposure for 60 min under the experimental conditions
for this study. The survival of groups of mice for 100 days after
infection with M. tuberculosis or M. bovis BCG Pasteur was recorded, and survival curves were plotted. The lungs from IL-18-KO, WT, and IFN-
-KO mice (five mice each) (21) were retrieved from infected mice 10, 30, and 50 days
after airborne infection, homogenized, diluted, plated on Ogawa slant medium, and incubated at 37°C for 21 days, and the colonies were counted.
Histology.
Some mice were sacrificed 50 days after
infection, and some were monitored for up to 100 days postinfection.
Tissue sections (5 µm thick) from paraffin blocks containing lung,
liver, and spleen tissue were stained with hematoxylin and eosin or by
the Ziehl-Neelsen method for acid-fast bacilli. We prepared every lung tissue with white nodular lesions. The sizes of the 10 granulomas were measured with a micrometer (Nikon Optical Co., Tokyo, Japan).
Cytokine assays.
In order to determine whether the splenic
cells of IL-18-KO mice secrete IFN-
, the spleens were harvested from
the IL-18-deficient and WT mice and single cell suspensions were
prepared. The cell suspensions were plated (5 × 105
cells/well) in 96-well culture plates and incubated for 3 days at
37°C in 5% CO2 in air, and the cells were stimulated
with either medium alone or medium containing concanavalin A (ConA, 5 µg/ml), purified protein derivative (10 µg/ml), or live BCG
organisms (103 CFU/well). The concentrations of IL-4,
IL-10, IL-12, IL-1
, IFN-
, and tumor necrosis factor alpha
(TNF-
) in the culture supernatants of the cells incubated in the
presence of the above reagents were measured by sandwich ELISA
(Biosource International, Calif.).
RT-PCR.
Spleen tissue samples were taken from infected mice
14 or 50 days after infection, frozen in liquid nitrogen, and stored at
80°C until required for use, when RNA was extracted as described previously (3). Reverse transcriptase (RT)-PCR was carried out with gene-specific primer sets for inducible NO synthase (iNOS), TNF-
, IFN-
, IL-12, IL-1
, and IL-18 (CLP Inc.) the respective sizes of which were 306, 276, 405, 850, and 447 bp. The size of
-actin used as a positive control was 514 bp. The same amounts of
-actin RNA from the spleen tissues used as an internal control were
used in RT-PCR analysis.
Macrophage NO assay.
Peritoneal adherent macrophages (5 × 105/well) in RPMI 1640 supplemented with 10% (vol/vol)
fetal calf serum were plated in 96-well culture plates, unstimulated or
stimulated with recombinant IL-18 (100 ng/well; Pepro Tech) or IFN-
(1,000 international units [IU]; Genzyme), and then cultured with the
BCG or Kurono strain overnight. IFN-
was added to determine whether
it was able to activate macrophages from the KO mice. The supernatants were collected 36 h after the cultures were seeded and filtered, and the nitrite concentrations were determined by the Griess assay, as
described previously (7).
Reconstitution of IL-18-deficient mice with exogenous IL-18.
Mice were injected subcutaneously with 10 µg of recombinant IL-18
(Pepro Tech) in PBS or PBS alone four times at weekly intervals. The
biological activity of the recombinant IL-18 was evaluated by
determining the 50% effective dose (12 ng/ml) by measuring the
concentration-dependent stimulation of IFN-
production by murine
lymph node cells (4 × 105 cells/well) costimulated
with ConA at a suboptimal concentration (750 ng/ml). The lungs
from IL-18-KO mice treated subcutaneously with recombinant IL-18 were
retrieved from the infected mice 7 weeks after airborne infection.
Statistical methods.
The values were compared by Student's
t test. For all statistical analyses, a P value
of <0.01 was considered significant.
 |
RESULTS |
KO and WT littermates were infected i.v. (106 to
107 CFU) or by the airborne route (105 CFU)
with virulent M. tuberculosis Kurono. All the KO and WT mice survived until the date of sacrifice (100 days after infection). When 107 CFU of the Kurono strain was given i.v. to five KO
mice, one mouse died by 86 days postinfection (Fig.
1). Figure
2 shows the CFU in lung tissues of
IL-18-KO, WT, and IFN-
-KO mice inoculated with 106 CFU
of the Kurono strain by the airborne route. The number of CFU in lung
tissues from IL-18-KO mice was higher than that of WT mice but lower
than that of IFN-
-KO mice.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Survival curves of mice infected with M. tuberculosis or M. bovis BCG Pasteur. IL-18-KO and
WT mice were infected i.v. with 106 CFU of the Kurono or
BCG Pasteur strain. Data presented are from two separate experiments
with 10 mice in each group.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
CFU in lung tissues of IL-18-KO, WT, and IFN- -KO mice
(12 mice each) exposed to 106 CFU of M. tuberculosis by the airborne route. At the indicated days after
infection, four mice from each group were sacrificed and homogenates of
lung tissues were plated. IFN- -KO mice were used as positive
controls. Error bars indicate standard errors of the means.
|
|
When 107 CFU of the Kurono strain was administered i.v. to
KO mice, larger granulomas were observed in their lungs and spleens than in those of the WT controls (Fig.
3A). The average
diameter of all granulomas in the lungs of IL-18-KO mice was
18,620 ± 430 µm, whereas that of WT mice was 5,880 ± 300 µm (P < 0.01). No necrotic lesions were present in
the major organs. Hardly any granulomas were found in the organs of the
WT mice. Similar pathological profiles were observed after infection by
the airborne route, and numerous bacteria were present in the
granulomatous lesions (Fig. 3B).

View larger version (108K):
[in this window]
[in a new window]
|
FIG. 3.
Histologic examination of lung tissues. Mice were killed
7 weeks after infection, and formalin-fixed sections were stained with
hematoxylin and eosin (A, C, D, and E) and for acid-fast bacilli (B).
(A) Tissue from IL-18-KO mice infected with the Kurono strain. A large,
indiscrete granuloma with foamy macrophages is noted. Magnification,
×100. (B) Tissue from IL-18-KO mice infected with the Kurono strain.
Mycobacteria stained red and are recognized in the granuloma by
Ziehl-Neelsen staining. Magnification, ×600. (C) Tissue from WT mice
infected with the Kurono strain. A small, discrete granuloma was
formed. Magnification, ×100. (D) Tissue from IL-18-KO mice infected
with the Kurono strain and treated four times subcutaneously with
recombinant IL-18. The granuloma became smaller. Magnification, ×200.
(E) Tissue from WT mice infected with BCG Pasteur. No granuloma was
recognized. Alveolar septal thickening was noted. Magnification,
×100.
|
|
As the defect in the KO mice was genetically defined, the possibility
of recovering immune response function by administering exogenous
recombinant IL-18 was investigated. When IL-18 was given subcutaneously, the sizes of the granulomatous lesions were reduced significantly (mean diameter, 4,820 ± 153 µm), and there were virtually no bacteria in the lesions (Fig. 3C). Significantly less iNOS
and TNF-
mRNA was produced by spleen cells of IL-18-KO mice than by
those of untreated KO mice (Fig. 4).
Thus, treatment with exogenous IL-18 reduced the bacterial load
(104 versus 106 CFU), indicating that IL-18
plays an important role in the immune response to M. tuberculosis.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
In vivo expression of various cytokines and iNOS mRNA in
Kurono strain-infected mice by RT-PCR. The spleen tissues of IL-18-KO
(lanes 1, 3, 4, 6, 7, 9, 11, 13, and 15) and WT (lanes 2, 5, 8, 10, 12, and 14) mice were removed 7 weeks after infection. M, size marker;
lanes: 1, IL-18 from IL-18-KO mouse (no amplified band); 2 to 4, TNF- (no TNF- in IL-18-KO mice treated with recombinant IL-18
[lane 4]); 5 to 7, iNOS (almost no amplified band in IL-18-KO mice
treated with recombinant IL-18 [lane 7]); 8 and 9, IL-12; 10 and 11, IL-1 ; 12 and 13, IFN- ; 14 and 15, -actin.
|
|
In order to examine the major cytokine mRNA expression profiles of
IL-18-KO mice, RT-PCR analysis of the infected spleens was carried out.
No splenic IL-18 mRNA expression was detected in any IL-18-KO mouse
(Fig. 4). IFN-
, TNF-
, and iNOS mRNA was expressed to a moderate
degree, but the IL-1
and IL-12 mRNA expression levels were somewhat
lower. The IFN-
, TNF-
, iNOS, IL-1
, and IL-12 mRNA
expression levels in the infected mice were significantly lower than
those in the WT mice.
In order to determine whether the absence of IL-18 influenced the
induction and control of other cytokines, the levels of several
cytokines in the culture supernatants of spleen cells were determined
by sandwich ELISA. As shown in Table 1,
spleen cells of KO mice produced significantly less IL-1
than those of WT mice.
The NO levels in peritoneal macrophage supernatants were
determined by the Griess assay and referred to a standard
NaNO2 curve. The levels of NO production by unstimulated
peritoneal macrophages from WT and KO mice were low (Fig.
5). When peritoneal macrophages from KO
mice were stimulated overnight with either the BCG Pasteur or Kurono
strain, the NO levels increased to 42 µM (KO mice) and 61 µM (WT
control). When 100 ng of recombinant IL-18 was added to cultures
of macrophages from KO mice, NO production increased to a moderate
degree (57 µM). When 1,000 IU of IFN-
was added to macrophages
of KO and WT mice, NO production increased to 64 and 65 µM,
respectively.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Nitric oxide production by the peritoneal macrophages
from IL-18-KO and WT mice stimulated with the Kurono strain overnight
in the presence or absence of recombinant IL-18 or with IFN- .
Thereafter, the NO-producing ability of the macrophages was determined
by the Griess reagent.
|
|
 |
DISCUSSION |
We have found that large granulomas were induced by inoculation of
an M. tuberculosis strain but that necrotic lesions
were not recognized in major organs. IFN-
production by spleen cells from KO mice was reduced moderately, but neither IL-12, TNF-
, IL-4,
nor IL-10 secretion by cells of KO and WT mice differed significantly.
Therefore, the expression of Th2 cytokine mRNA, including IL-4 and
IL-10 mRNA, does not contribute to the progress of mycobacterial
infection in this experimental system. The splenic IFN-
level in
IL-18-KO mice was significantly lower than that in WT mice,
demonstrating that IL-18 plays an important role in IFN-
production.
However, exogenous IFN-
and IL-18 were still able to activate the
peritoneal macrophages of IL-18-KO mice to various degrees. The IL-12
levels after mitogenic in vitro challenge of spleen cells from IL-18 KO
and WT mice were almost the same, suggesting that the reduced IFN-
production was not secondary to a low level of induction of IL-12
secretion. Together with the RT-PCR data, these data suggest that Th1
and NK cells of IL-18-KO mice are still able to produce IFN-
,
although the NK cell activity and Th1-mediated responses of these
IL-18-deficient mice are compromised (23). It is interesting
that mice devoid of IL-18 production can secrete IFN-
to a moderate
degree and exogenous IFN-
still can activate macrophages from these
mice. NK cells and NK T cells may secrete IFN-
as a compensatory function.
IL-18 has been reported to protect mice against pulmonary and
disseminated infection with Cryptococcus neoformans by
inducing IFN-
production (9). When recombinant IL-18 was
administered subcutaneously, the sizes of the granulomas were reduced
significantly (P < 0.01). Therefore, changing the
therapeutic regimens administered to the experimental model mice in our
study may enable mycobacterial infection to be prevented
completely. iNOS and TNF-
mRNA produced by spleen cells of IL-18-KO
mice was significantly less than by untreated KO mice. Thus, treatment
with exogenous IL-18 reduced the bacterial load, indicating that
IL-18 plays an important role in the immune response to M. tuberculosis. This finding contrasts with the findings that the
sizes of the granulomatous lesions in IFN-
-KO and TNF-
-KO mice
infected with M. tuberculosis were not reduced
significantly by recombinant IFN-
or TNF-
(8, 21).
IL-18 may play a pivotal role in the immunotherapy of tuberculosis.
It has been reported that IL-18 induces IL-8 and IL-1
via TNF-
production from non-CD14-positive human blood mononuclear cells
(19). In our experiments, IL-18-KO mice expressed far less
IL-1
mRNA than did the WT counterpart. This finding was also
confirmed by ELISA in that the level of IL-1
secretion was lower
than that in WT mice. Further study will be required to explain this
interesting observation.
In summary, we demonstrated that IL-18 influenced the
course of mycobacterial infection in mice. The inflammatory
lesions in IL-18-KO mice were no more severe than those observed
in IFN-
-KO (4, 6), IL-12-KO (5), and
TNF-
-KO mice (8). Therefore, IL-18 does not seem to play
a role in Mycobacterium-induced granuloma formation.
Like IL-12-KO mice, IL-18-KO mice displayed reduced IFN-
production
in vivo relative to that in WT mice, although secretion of IL-12 by
antigen-challenged spleen cells in vitro was almost normal. These
findings suggest that IL-18 is an important factor involved in IFN-
production in vivo and that IL-18 deficiency cannot be compensated for
by IL-12 and other cytokines.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Pathology, The Research Institute of Tuberculosis, Japan
Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose, Tokyo
204-0022, Japan. Phone: 81 424 92 5075. Fax: 81 424 92 4600. E-mail:
sugawara{at}jata.or.jp.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Bazan, J. F.,
J. C. Timans, and R. A. Kastelein.
1996.
A newly defined interleukin-1?
Nature
79:591.
|
| 2.
|
Belosevic, M.,
C. E. Davis,
M. S. Meltzer, and C. A. Nacy.
1988.
Regulation of activated macrophage antimicrobial activities: identification of lymphokines that cooperate with interferon gamma for induction of macrophage resistance to infection.
J. Immunol.
141:890-896[Abstract].
|
| 3.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 4.
|
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russel, and I. M. Orme.
1993.
Disseminated tuberculosis in interferon- gene-disrupted mice.
J. Exp. Med.
178:2243-2247[Abstract/Free Full Text].
|
| 5.
|
Cooper, A. M.,
J. Magram,
J. Ferrante, and I. M. Orme.
1997.
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis.
J. Exp. Med.
186:39-45[Abstract/Free Full Text].
|
| 6.
|
Flynn, J. L.,
J. Chan,
K. J. Triebold,
D. K. Dalton,
T. A. Stewart, and B. R. Bloom.
1993.
An essential role for interferon in resistance to Mycobacterium tuberculosis infection.
J. Exp. Med.
178:2249-2254[Abstract/Free Full Text].
|
| 7.
|
Green, S. J.,
R. M. Crawford,
J. T. Hockmeyer,
M. S. Meltzer, and C. A. Nacy.
1990.
Leishmania major amastigotes initiate the 1-arginine-dependent killing mechanism in IFN- stimulated macrophages by induction of tumor necrosis factor- .
J. Immunol.
145:4290-4297[Abstract].
|
| 8.
| Kaneko, H., H. Yamada, Y. Kazumi, S. Mizuno, K. Sekikawa, and I. Sugawara. The role of tumor necrosis factor
(TNF)-alpha in Mycobacterium-induced granuloma formation in
TNF-alpha deficient mice. Lab. Invest., in press.
|
| 9.
|
Kawakami, K.,
H. Q. Mahboob,
T. Zhang,
H. Okumura,
M. Kurimoto, and A. Saito.
1997.
IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN- production.
J. Immunol.
159:5528-5534[Abstract].
|
| 10.
|
Kinderlen, A. F.,
S. H. Kaufmann, and M. L. Lohmann-Matthes.
1984.
Protection of mice against the intracellular bacteria Listeria monocytogenes by recombinant interferon.
Eur. J. Immunol.
14:964-967[Medline].
|
| 11.
|
Kohno, K.,
J. Kataoka,
T. Otsuki,
Y. Suemoto,
I. Okamoto,
M. Usui,
M. Ikeda, and M. Kurimoto.
1997.
IFN- -inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
J. Immunol.
158:1541-1550[Abstract].
|
| 12.
|
Mackaness, G. B.
1962.
Cellular resistance to infection.
J. Exp. Med.
11:381-406.
|
| 13.
|
Matsui, K.,
T. Yoshimoto,
H. Tsutsui,
Y. Hyodo,
N. Hayashi,
K. Hiroishi,
N. Kawada,
H. Okamura,
K. Nakanishi, and K. Higashimoto.
1997.
Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
J. Immunol.
159:97-106[Abstract].
|
| 14.
|
Murray, H. W.,
B. Y. Rubin, and C. D. Rothermel.
1983.
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: evidence that interferon gamma is the activating lymphokine.
J. Clin. Invest.
72:1506-1510.
|
| 15.
|
Okamura, H.,
K. Nagata,
T. Komatsu,
T. Tanimoto,
T. Nukata,
Y. Tanabe,
K. Akita,
K. Torigoe,
T. Okura, and S. Fukuda.
1995.
A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxin shock.
Infect. Immun.
63:3966-3972[Abstract].
|
| 16.
|
Okamura, H.,
H. Tsutsui,
T. Komatsu,
M. Yutsudo,
A. Hakura,
T. Tanimoto,
T. Torigoe,
T. Okura,
Y. Nukada, and K. Hattori.
1995.
Cloning of a new cytokine that induces IFN- production by T cells.
Nature
378:88-91[Medline].
|
| 17.
|
Orme, I.
1987.
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.
J. Immunol.
138:293-298[Abstract].
|
| 18.
|
Orme, I. M.,
E. S. Miller,
A. D. Roberts,
S. K. Furney,
J. P. Griffin,
K. M. Dobos,
D. Chi,
B. Rivoire, and P. J. Brennan.
1992.
T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection.
J. Immunol.
148:189-196[Abstract].
|
| 19.
|
Puren, A. J.,
G. Fantuzzi,
Y. Gu,
M. S. Su, and C. A. Dinarello.
1998.
Interleukin-18 (IFN- -inducing factor) induces IL-8 and IL-1 via TNF- production from non-CD14+ human blood mononuclear cells.
J. Clin. Invest.
101:711-721[Medline].
|
| 20.
|
Schreiber, R. D., and A. Celada.
1985.
A molecular characterization of interferon as a macrophage activating factor.
Lymphokines
11:87-118.
|
| 21.
|
Sugawara, I.,
H. Yamada,
Y. Kazumi,
N. Doi,
K. Otomo,
T. Aoki,
S. Mizuno,
T. Udagawa,
Y. Tagawa, and Y. Iwakura.
1998.
Granulomas in interferon gene-disrupted mice are inducible by avirulent Mycobacterium, but not by virulent Mycobacterium.
J. Med. Microbiol.
47:871-877[Abstract/Free Full Text].
|
| 22.
|
Tagawa, Y.,
K. Sekikawa, and Y. Iwakura.
1997.
Suppression of concanavalin A-induced hepatitis in IFN- / , but not in TNF- / mice: role for IFN- in activating apoptosis in hepatocytes.
J. Immunol.
159:1418-1428[Abstract].
|
| 23.
|
Takeda, K.,
H. Tsutsui,
T. Yoshimoto,
O. Adachi,
N. Yoshida,
T. Kishimoto,
H. Okamura,
K. Nakanishi, and S. Akira.
1998.
Defective NK activity and Th1 response in IL-18-deficient mice.
Immunity
8:383-390[Medline].
|
| 24.
|
Ushio, S.,
M. Namba,
T. Okura,
K. Hattori,
Y. Nukada,
K. Akita,
F. Tanabe,
K. Konishi,
M. Micallef, and M. Fujii.
1996.
Cloning of the cDNA for human IFN- -inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein.
J. Immunol.
156:4274-4279[Abstract].
|
| 25.
|
Vilcek, J.,
E. Rinderknecht, and C. G. Sevastopoulos.
1985.
Interferon : a lymphokine for all seasons.
Lymphokines
11:1-32.
|
Infection and Immunity, May 1999, p. 2585-2589, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Haring, J. S., Harty, J. T.
(2009). Interleukin-18-Related Genes Are Induced during the Contraction Phase but Do Not Play Major Roles in Regulating the Dynamics or Function of the T-Cell Response to Listeria monocytogenes Infection. Infect. Immun.
77: 1894-1903
[Abstract]
[Full Text]
-
Sporri, R., Joller, N., Hilbi, H., Oxenius, A.
(2008). A Novel Role for Neutrophils As Critical Activators of NK Cells. J. Immunol.
181: 7121-7130
[Abstract]
[Full Text]
-
Lochner, M., Kastenmuller, K., Neuenhahn, M., Weighardt, H., Busch, D. H., Reindl, W., Forster, I.
(2008). Decreased Susceptibility of Mice to Infection with Listeria monocytogenes in the Absence of Interleukin-18. Infect. Immun.
76: 3881-3890
[Abstract]
[Full Text]
-
Yamada, H., Mizuno, S., Ross, A. C., Sugawara, I.
(2007). Retinoic Acid Therapy Attenuates the Severity of Tuberculosis While Altering Lymphocyte and Macrophage Numbers and Cytokine Expression in Rats Infected with Mycobacterium tuberculosis. J. Nutr.
137: 2696-2700
[Abstract]
[Full Text]
-
Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., Quesniaux, V. F. J.
(2007). IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. J. Immunol.
179: 1178-1189
[Abstract]
[Full Text]
-
Skokos, D., Nussenzweig, M. C.
(2007). CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. JEM
204: 1525-1531
[Abstract]
[Full Text]
-
Bachmann, M., Dragoi, C., Poleganov, M. A., Pfeilschifter, J., Muhl, H.
(2007). Interleukin-18 directly activates T-bet expression and function via p38 mitogen-activated protein kinase and nuclear factor-{kappa}B in acute myeloid leukemia-derived predendritic KG-1 cells. Molecular Cancer Therapeutics
6: 723-731
[Abstract]
[Full Text]
-
Vesosky, B., Flaherty, D. K., Turner, J.
(2006). Th1 Cytokines Facilitate CD8-T-Cell-Mediated Early Resistance to Infection with Mycobacterium tuberculosis in Old Mice.. Infect. Immun.
74: 3314-3324
[Abstract]
[Full Text]
-
Wieland, C. W., Florquin, S., Pater, J. M., Weijer, S., van der Poll, T.
(2006). CD4+ Cells Play a Limited Role in Murine Lung Infection with Mycobacterium kansasii. Am. J. Respir. Cell Mol. Bio.
34: 167-173
[Abstract]
[Full Text]
-
Tanaka, S., Sato, M., Onitsuka, T., Kamata, H., Yokomizo, Y.
(2005). Inflammatory Cytokine Gene Expression in Different Types of Granulomatous Lesions during Asymptomatic Stages of Bovine Paratuberculosis. Vet Pathol
42: 579-588
[Abstract]
[Full Text]
-
Shi, S., Blumenthal, A., Hickey, C. M., Gandotra, S., Levy, D., Ehrt, S.
(2005). Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-{alpha}{beta} Receptor and STAT1. J. Immunol.
175: 3318-3328
[Abstract]
[Full Text]
-
Fernandez-Lago, L., Orduna, A., Vizcaino, N.
(2005). Reduced interleukin-18 secretion in Brucella abortus 2308-infected murine peritoneal macrophages and in spleen cells obtained from B. abortus 2308-infected mice. J Med Microbiol
54: 527-531
[Abstract]
[Full Text]
-
Montero, M. T., Matilla, J., Gomez-Mampaso, E., Lasuncion, M. A.
(2004). Geranylgeraniol Regulates Negatively Caspase-1 Autoprocessing: Implication in the Th1 Response against Mycobacterium tuberculosis. J. Immunol.
173: 4936-4944
[Abstract]
[Full Text]
-
Hallstrand, T.S., Ochs, H.D., Zhu, Q., Liles, W.C.
(2004). Inhaled IFN-{gamma} for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-{gamma} deficiency. Eur Respir J
24: 367-370
[Abstract]
[Full Text]
-
Coussens, P. M.
(2004). Model for Immune Responses to Mycobacterium avium Subspecies paratuberculosis in Cattle. Infect. Immun.
72: 3089-3096
[Full Text]
-
Scanga, C. A., Bafica, A., Feng, C. G., Cheever, A. W., Hieny, S., Sher, A.
(2004). MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression. Infect. Immun.
72: 2400-2404
[Abstract]
[Full Text]
-
Coussens, P. M., Verman, N., Coussens, M. A., Elftman, M. D., McNulty, A. M.
(2004). Cytokine Gene Expression in Peripheral Blood Mononuclear Cells and Tissues of Cattle Infected with Mycobacterium avium subsp. paratuberculosis: Evidence for an Inherent Proinflammatory Gene Expression Pattern. Infect. Immun.
72: 1409-1422
[Abstract]
[Full Text]
-
Liu, B., Mori, I., Hossain, M. J., Dong, L., Takeda, K., Kimura, Y.
(2004). Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol.
85: 423-428
[Abstract]
[Full Text]
-
Elhage, R., Jawien, J., Rudling, M., Ljunggren, H.-G., Takeda, K., Akira, S., Bayard, F., Hansson, G. K
(2003). Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res
59: 234-240
[Abstract]
[Full Text]
-
Gracie, J. A., Robertson, S. E., McInnes, I. B.
(2003). Interleukin-18. J. Leukoc. Biol.
73: 213-224
[Abstract]
[Full Text]
-
Sugawara, I., Yamada, H., Mizuno, S.
(2003). Relative importance of STAT4 in murine tuberculosis. J Med Microbiol
52: 29-34
[Abstract]
[Full Text]
-
Biet, F., Kremer, L., Wolowczuk, I., Delacre, M., Locht, C.
(2002). Mycobacterium bovis BCG Producing Interleukin-18 Increases Antigen-Specific Gamma Interferon Production in Mice. Infect. Immun.
70: 6549-6557
[Abstract]
[Full Text]
-
Rouabhia, M., Ross, G., Page, N., Chakir, J.
(2002). Interleukin-18 and Gamma Interferon Production by Oral Epithelial Cells in Response to Exposure to Candida albicans or Lipopolysaccharide Stimulation. Infect. Immun.
70: 7073-7080
[Abstract]
[Full Text]
-
Dreher, D., Kok, M., Obregon, C., Kiama, S. G., Gehr, P., Nicod, L. P.
(2002). Salmonella virulence factor SipB induces activation and release of IL-18 in human dendritic cells. J. Leukoc. Biol.
72: 743-751
[Abstract]
[Full Text]
-
Abel, B., Thieblemont, N., Quesniaux, V. J. F., Brown, N., Mpagi, J., Miyake, K., Bihl, F., Ryffel, B.
(2002). Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice. J. Immunol.
169: 3155-3162
[Abstract]
[Full Text]
-
Kinjo, Y., Kawakami, K., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Hoshino, T., Okamoto, M., Kawase, Y., Yokota, K., Yoshino, K., Takeda, K., Akira, S., Saito, A.
(2002). Contribution of IL-18 to Th1 Response and Host Defense Against Infection by Mycobacterium tuberculosis: A Comparative Study with IL-12p40. J. Immunol.
169: 323-329
[Abstract]
[Full Text]
-
Stuyt, R. J. L., Netea, M. G., Verschueren, I., Fantuzzi, G., Dinarello, C. A., Van der Meer, J. W. M., Kullberg, B. J.
(2002). Role of Interleukin-18 in Host Defense against Disseminated Candida albicans Infection. Infect. Immun.
70: 3284-3286
[Abstract]
[Full Text]
-
Ho, L.-P., Davis, M., Denison, A., Wood, F. T., Greening, A. P.
(2002). Reduced Interleukin-18 Levels in BAL Specimens From Patients With Asthma Compared to Patients With Sarcoidosis and Healthy Control Subjects*. Chest
121: 1421-1426
[Abstract]
[Full Text]
-
Tanaka, H., Narita, M., Teramoto, S., Saikai, T., Oashi, K., Igarashi, T., Abe, S.
(2002). Role of Interleukin-18 and T-helper Type 1 Cytokines in the Development of Mycoplasma pneumoniae Pneumonia in Adults*. Chest
121: 1493-1497
[Abstract]
[Full Text]
-
Singh, R. P., Kashiwamura, S.-i., Rao, P., Okamura, H., Mukherjee, A., Chauhan, V. S.
(2002). The Role of IL-18 in Blood-Stage Immunity Against Murine Malaria Plasmodium yoelii265 and Plasmodium bergheiANKA. J. Immunol.
168: 4674-4681
[Abstract]
[Full Text]
-
van Crevel, R., Ottenhoff, T. H. M., van der Meer, J. W. M.
(2002). Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev.
15: 294-309
[Abstract]
[Full Text]
-
Smith, S., Liggitt, D., Jeromsky, E., Tan, X., Skerrett, S. J., Wilson, C. B.
(2002). Local Role for Tumor Necrosis Factor Alpha in the Pulmonary Inflammatory Response to Mycobacterium tuberculosis Infection. Infect. Immun.
70: 2082-2089
[Abstract]
[Full Text]
-
SUGAWARA, I., UDAGAWA, T., HUA, S.C., REZA-GHOLIZADEH, M., OTOMO, K., SAITO, Y., YAMADA, H.
(2002). Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate. J Med Microbiol
51: 131-137
[Abstract]
[Full Text]
-
Moore, B.B., Moore, T.A., Toews, G.B.
(2001). Role of T- and B-;lymphocytes in pulmonary host defences. Eur Respir J
18: 846-856
[Abstract]
[Full Text]
-
Yamada, H., Mizuno, S., Reza-Gholizadeh, M., Sugawara, I.
(2001). Relative Importance of NF-kappa B p50 in Mycobacterial Infection. Infect. Immun.
69: 7100-7105
[Abstract]
[Full Text]
-
Fairbairn, I. P., Stober, C. B., Kumararatne, D. S., Lammas, D. A.
(2001). ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion. J. Immunol.
167: 3300-3307
[Abstract]
[Full Text]
-
Del Rio, L., Buendia, A. J., Sanchez, J., Gallego, M. C., Caro, M. R., Ortega, N., Seva, J., Pallares, F. J., Cuello, F., Salinas, J.
(2001). Endogenous Interleukin-12 Is Not Required for Resolution of Chlamydophila abortus (Chlamydia psittaci Serotype 1) Infection in Mice. Infect. Immun.
69: 4808-4815
[Abstract]
[Full Text]
-
Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., Coccia, E. M.
(2001). Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response. J. Immunol.
166: 7033-7041
[Abstract]
[Full Text]
-
Vankayalapati, R., Wizel, B., Lakey, D. L., Zhang, Y., Coffee, K. A., Griffith, D. E., Barnes, P. F.
(2001). T Cells Enhance Production of IL-18 by Monocytes in Response to an Intracellular Pathogen. J. Immunol.
166: 6749-6753
[Abstract]
[Full Text]
-
Boechat, N., Bouchonnet, F., Bonay, M., Grodet, A., Pelicic, V., Gicquel, B., Hance, A. J.
(2001). Culture at High Density Improves the Ability of Human Macrophages to Control Mycobacterial Growth. J. Immunol.
166: 6203-6211
[Abstract]
[Full Text]
-
Rook, G.A.W., Seah, G., Ustianowski, A.
(2001). M. tuberculosis: immunology and vaccination. Eur Respir J
17: 537-557
[Abstract]
[Full Text]
-
Brieland, J. K., Jackson, C., Menzel, F., Loebenberg, D., Cacciapuoti, A., Halpern, J., Hurst, S., Muchamuel, T., Debets, R., Kastelein, R., Churakova, T., Abrams, J., Hare, R., O'Garra, A.
(2001). Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus. Infect. Immun.
69: 1554-1560
[Abstract]
[Full Text]
-
Dietrich, W. F.
(2001). Using Mouse Genetics to Understand Infectious Disease Pathogenesis. Genome Res
11: 325-331
[Full Text]
-
Sugawara, I., Mizuno, S., Yamada, H., Matsumoto, M., Akira, S.
(2001). Disruption of Nuclear Factor-Interleukin-6, a Transcription Factor, Results in Severe Mycobacterial Infection. Am. J. Pathol.
158: 361-366
[Abstract]
[Full Text]
-
Lertmemongkolchai, G., Cai, G., Hunter, C. A., Bancroft, G. J.
(2001). Bystander Activation of CD8+ T Cells Contributes to the Rapid Production of IFN-{{gamma}} in Response to Bacterial Pathogens. J. Immunol.
166: 1097-1105
[Abstract]
[Full Text]
-
Wei, X.-q., Leung, B. P., Arthur, H. M. L., McInnes, I. B., Liew, F. Y.
(2001). Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18. J. Immunol.
166: 517-521
[Abstract]
[Full Text]
-
Brieland, J. K., Jackson, C., Hurst, S., Loebenberg, D., Muchamuel, T., Debets, R., Kastelein, R., Churakova, T., Abrams, J., Hare, R., O'Garra, A.
(2000). Immunomodulatory Role of Endogenous Interleukin-18 in Gamma Interferon-Mediated Resolution of Replicative Legionella pneumophila Lung Infection. Infect. Immun.
68: 6567-6573
[Abstract]
[Full Text]
-
Russo, D. M., Kozlova, N., Lakey, D. L., Kernodle, D.
(2000). Naive Human T Cells Develop into Th1 Effectors after Stimulation with Mycobacterium tuberculosis-Infected Macrophages or Recombinant Ag85 Proteins. Infect. Immun.
68: 6826-6832
[Abstract]
[Full Text]
-
Cai, G., Kastelein, R., Hunter, C. A.
(2000). Interleukin-18 (IL-18) Enhances Innate IL-12-Mediated Resistance to Toxoplasma gondii. Infect. Immun.
68: 6932-6938
[Abstract]
[Full Text]
-
Song, C.-H., Kim, H.-J., Park, J.-K., Lim, J.-H., Kim, U.-O., Kim, J.-S., Paik, T.-H., Kim, K.-J., Suhr, J.-W., Jo, E.-K.
(2000). Depressed Interleukin-12 (IL-12), but not IL-18, Production in Response to a 30- or 32-Kilodalton Mycobacterial Antigen in Patients with Active Pulmonary Tuberculosis. Infect. Immun.
68: 4477-4484
[Abstract]
[Full Text]
-
YAMADA, G., SHIJUBO, N., SHIGEHARA, K., OKAMURA, H., KURIMOTO, M., ABE, S.
(2000). Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis. Am. J. Respir. Crit. Care Med.
161: 1786-1789
[Abstract]
[Full Text]
-
Monteforte, G. M., Takeda, K., Rodriguez-Sosa, M., Akira, S., David, J. R., Satoskar, A. R.
(2000). Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection. J. Immunol.
164: 5890-5893
[Abstract]
[Full Text]